Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma. Radiol Oncol [Internet]. 2015 Oct. 8 [cited 2026 Sep. 25];49(3). Available from: https://radioloncol.com/index.php/ro/article/view/2368